ALICIA DURHAM: Open Payments
NPI 1629301312 · ATHENS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 26 payments from 8 companies in 2025. Trend: 2023 $481 · 2024 $660 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Axsome Therapeutics, Inc. | 2 | $81 |
| PFIZER INC. | 3 | $47 |
| Lilly USA, LLC | 2 | $44 |
| ABBVIE INC. | 1 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: CAPLYTA, Auvelity, Rybelsus, Ozempic, JARDIANCE, VRAYLAR, Wegovy, ELIQUIS.
Industry payments across TN — which companies pay providers there.
